header image

[Sign Up Now] to Receive Our FREE Daily SCVTV-SCVNews Digest by E-Mail

Inside
Weather


 
Calendar
Today in
S.C.V. History
November 9
1898 - Actress Winifred Westover born in Oakland; estranged wife of William S. Hart & mother of his son. [story]
Winifred Westover


WASHINGTON — Touted enthusiastically by the nation’s chief infectious disease specialist Dr. Anthony Fauci, the biotechnology giant Moderna announced on Monday that its vaccine for the novel coronavirus is 94.5% effective.

“These are obviously very exciting results. It’s just as good as it gets — 94.5% is truly outstanding,” Fauci told CNN early Monday morning.

Moderna, based in Cambridge, Massachusetts, is the second company in as many weeks to announce major breakthroughs in vaccine development against COVID-19. Last week, pharmaceutical giant Pfizer announced its vaccine was over 90% effective in treating the respiratory virus.

Moderna CEO Stephane Bancel said the company has “chased” the novel coronavirus since January.

“All along, we have known that each day matters. This positive interim analysis from our Phase 3 study has given us the first clinical validation that our vaccine can prevent COVID-19 disease, including severe disease,” he said in a statement Monday.

The third phase of Moderna’s trial on a coronavirus vaccine candidate involved some 30,000 participants, half of which took a placebo while the other half received the actual vaccine under development.

Of the 15,000 test subjects given a placebo, Moderna said Monday that only 90 of those individuals contracted Covid-19. Less than a dozen placebo-consumers contracted a more severe form of the virus.

Among the 15,000 participants who actually took the vaccine, just five became infected with COVID-19 and none became severely ill. Side effects from the clinical trial vaccine, for now, appear minimal.

“Preliminary analysis suggests a broadly consistent safety and efficacy profile across all evaluated subgroups,” Moderna said in its announcement.

To expedite distribution, the company plans on pursuing emergency-use authorization from the Food and Drug Administration after it completes its final safety evaluations.

It is widely expected that any vaccine emerging in the months ahead, be it from Moderna or another company, will see limited initial distribution. Fauci said Monday he expects the first round of vaccines to be administered in late December.

Those doses will first go to the most vulnerable populations including the elderly or severely immunocompromised. Health care workers, nurses and doctors, among others combatting the virus on the front lines, will also receive the vaccine first. For now, the Centers for Disease Control and Prevention are expected to lead the coordination of the nationwide vaccine rollout.

Fauci said Monday he believes that by the end of April 2021, “everybody else” will start to get vaccinated. That process could take at least a few months to complete, he warned.

Moderna estimates at least 20 million doses will be available by the end of 2020. Pfizer projects a supply of 50 million doses available by the end of December as well.

Moderna’s vaccine, like Pfizer’s, uses something known as messenger ribonucleic acid or, mRNA to copy and synthesize proteins in the body that ultimately fend off the virus. Through mRNA, the vaccines direct a replication of spike proteins found atop the coronavirus cell. When this occurs, protective antibodies appear to be formed.

As part of administering both the Moderna and Pfizer vaccines, individuals must take two doses spread several weeks apart. Both vaccines also require special cold storage. But unlike Moderna’s vaccine, which can be stored at just -20 degrees Celsius, Pfizer’s candidate requires deep-freeze storage temperatures of -70 degrees Celsius.

This is a primary challenge to the supply chain, said Tinglong Dai, an assistant professor of operations and management and business analytics at Johns Hopkins University Carey Business School.

“Our cold- and ultra-cold-chain capacity might not be able to meet the transportation and storage requirements of the vaccines that will be chosen in the end,” Dai said in an email Monday. “Another challenge is we do not have adequate information systems for sharing vaccine availability information, placing requests for vaccines, and keeping track of who have been vaccinated and who have not.”

This will be “essential,” Dai told Courthouse News, when there could be not just one but two vaccines on the market, and those same vaccines are poised to initially require two doses per person.

The risk of having an abundance of ultra-cold or regular freezers and even overinvesting the federal purse into that market is possible. But Dai emphasized that the risk of the U.S. being unable to distribute a highly effective vaccine was obviously greater.

“In addition, it is essential for public health departments — at least at the state level — to build their information infrastructure as soon as possible,” he said.

Michael Breen, director of infectious disease and ophthalmology at the analytics group GlobalData, was encouraged by Moderna’s announcement Monday and, in particular, the way trials have underscored the potential success mRNA technology could have to treat emerging diseases.

But Breen also offered caution.

“With these two seemingly effective vaccines possibly weeks from entering the clinic through emergency-use authorization, the path forward for other developers now remains unclear,” Breen said in a statement. “While the most effective vaccines will ramp up production to meet global demand, the opportunity for less effective vaccines will wane — possibly leading the field to be winnowed sooner than later as developers may not see a lucrative future in a developing a vaccine, which, even if effective, may be used for only one year. Of course, the opportunity will still remain for multiple vaccines, even those with lower efficacy than offerings from Pfizer or Moderna, as those vaccines may not be available in all geographies, and those regions may go with their best vaccine option at the time.”

Moderna developed its vaccine candidate as part of a $1.5 billion contract from the U.S. government this August to produce and deliver 100 million doses, which is just enough for 50 million people. The United States has also retained an option in its contract with Moderna to purchase another 400 million doses after the initial rounds are administered.

That $1.5 billion deal was the result of the Trump administration’s vaccine task force, Operation Warp Speed. The research and development of the vaccine trials themselves were carried out thanks to a $955 million federal loan from the Biomedical Advanced Research and Development Authority.

Upon Moderna’s announcement, President Donald Trump — who has yet to concede his loss in the 2020 election to President-elect Joe Biden — took credit for the findings. Trump tweeted Monday: “Another Vaccine just announced. This time by Moderna, 95% effective. For those great ‘historians’, please remember that these great discoveries, which will end the China Plague, all took place on my watch!” [Punctuation in original.]

President-elect Joe Biden took a much different tack, saying the news of a second vaccine was “further reason to feel hopeful” but remain vigilant as the virus continues to course through America for its 10th month.

“What was true with the first vaccine remains true with the second: we are still months away,” Biden said. “Until then, Americans need to continue practice social distancing and mask-wearing to get the virus under control.”

As of Monday, the novel coronavirus has been on the rise in nearly all states. Since last week alone, the number of infections in America has jumped from 10 million cases to 11 million. Hospitalization and death rates are also on a steep incline across the U.S., which has lost 246,000 lives to the novel virus so far.

That death toll could double by the end of the year if the nation continues on its current trajectory, according to new projections from the University of Washington Institute for Health Metrics. Interviewed by CNN news anchor Jake Tapper on Sunday, Dr. Fauci agreed with the university’s grim assessment.

“I think that we likely will (see the doubling of fatalities from COVID-19), Jake, if we don’t turn around this surge.”

— By Brandi Buchman, CNS

Comment On This Story
COMMENT POLICY: We welcome comments from individuals and businesses. All comments are moderated. Comments are subject to rejection if they are vulgar, combative, or in poor taste.
REAL NAMES ONLY: All posters must use their real individual or business name. This applies equally to Twitter account holders who use a nickname.

0 Comments

You can be the first one to leave a comment.

Leave a Comment


SCV NewsBreak
LOCAL NEWS HEADLINES
Friday, Nov 8, 2024
UPDATE: Local Election Results as of Friday Evening
Unofficial election results for the 2024 General Election as of Friday, Nov. 8 at 5 p.m.
Friday, Nov 8, 2024
Nov. 12: Saugus Speedway Project, Garbage Fees, on City Council Agenda
The Santa Clarita City Council will hold its regular meeting Tuesday, Nov. 12, beginning with a special closed meeting at 5:30 p.m., followed immediately with open session at 6 p.m.
Friday, Nov 8, 2024
Nov. 23: Community Beautification Day
Want to make a difference in your community? Gather your friends and family for a rewarding day of giving back at the city of Santa Clarita’s Community Beautification Day in Saugus on Saturday, Nov. 23, 9 a.m.-noon for this cleanup and beautification day.
Keep Up With Our Facebook

Latest Additions to SCVNews.com
1898 - Actress Winifred Westover born in Oakland; estranged wife of William S. Hart & mother of his son. [story]
Winifred Westover
Unofficial election results for the 2024 General Election as of Friday, Nov. 8 at 5 p.m.
UPDATE: Local Election Results as of Friday Evening
The Santa Clarita City Council will hold its regular meeting Tuesday, Nov. 12, beginning with a special closed meeting at 5:30 p.m., followed immediately with open session at 6 p.m.
Nov. 12: Saugus Speedway Project, Garbage Fees, on City Council Agenda
Want to make a difference in your community? Gather your friends and family for a rewarding day of giving back at the city of Santa Clarita’s Community Beautification Day in Saugus on Saturday, Nov. 23, 9 a.m.-noon for this cleanup and beautification day.
Nov. 23: Community Beautification Day
The California Department of Transportation announced northbound overnight lane reductions on Interstate 5 from Lake Hughes Road to two miles north of Templin Highway, near the Whitaker Sand Shed, north of Castaic Wednesday night, Nov. 13 through Friday night, Nov. 15 for asphalt and concrete paving and box culvert construction.
Nov. 13-15: NB I-5 Lane Reductions Continue in Castaic Area
Step into a world of holiday fun! The city of Santa Clarita will partner with Metrolink to offer Santa Clarita residents a new, unique and festive activity this holiday season.
Dec. 15: Inaugural Metrolink Holiday Express Train
Each year the Santa Clarita Valley Economic Development Corporation, in collaboration with economist Dr. Mark Schniepp, releases the Economic Outlook Book.
2024 Economic Outlook Book Available From SCVEDC
College of the Canyons professors Katie Coleman and Mehgen Andrade will deliver the scholarly presentation “Behind Bars: Forfeiting our Children” 6 p.m. Thursday, Nov. 21 at the Santa Clarita Performing Arts Center, 26455 Rockwell Canyon Road, Santa Clarita, CA 91355.
Nov. 21: COC Scholarly Presentation Will Explore Juvenile Incarceration
1977 - Castaic residents vote 168-54 to withdraw 7th-8th grades from Hart District, making CUSD K-8 [story]
vote tally
The Child & Family Center has announced its Merry Mocktail Winter Wonderland Event Monday, Dec. 2, from 5-7 p.m. at 21545 Centre Pointe Parkway, Santa Clarita, CA 91350.
Dec. 2: Merry Mocktail Winter Wonderland Event
All For Kids is celebrating National Adoption Month by seeking foster families and now offers two virtual ways for individuals and/or couples to learn how to help children in foster care while reunifying with birth families or how to provide legal permanency by adoption.
Nov. 21: All For Kids Offering Virtual Orientations for National Adoption Month
Did you know that our local Santa Clarita Public Library offers passport acceptance services? Whether you’re planning a vacation, studying abroad or reconnecting with family, the Santa Clarita Public Library is here to support your journey.
Jason Gibbs | Get Your Passport at the Santa Clarita Public Library
Parents and caregivers are invited to Empowered Families Workshops hosted by the Child & Family Center’s Prevention and Outreach team in collaboration with First Presbyterian Church of Newhall beginning 2-3:30 p.m. Sunday, Nov. 10 with a workshop on Social Media and mental health.
Nov. 10: Child & Family Center, First Presbyterian Church Collab for Workshops
Samuel Dixon Family Health Center, Inc. has announced that it was awarded a $1.1 million grant from the Department of Health and Human Services Health Resources and Services Administration to add new services that will include substance use disorder treatment programs.
Samuel Dixon Awarded 1.1 Million Grant for SUD Program
The American Cancer Society Relay for Life of Santa Clarita Valley will host its annual holiday boutique fundraiser, 10 a.m.-3 p.m. Saturday, Nov. 23, at Santa Clarita United Methodist Church
Nov. 23: ACS Relay for Life SCV Holiday Boutique
The Santa Clarita Veteran Services Collaborative has announced the "Bringing it Home" fundraiser, an exclusive wine and hors d'oeuvre event hosted by Salt Creek Grille, will be held Thursday, Nov. 21.
Nov. 21: Salt Creek Grille, Veteran Services Collaborative Host Fundraiser
The U.S. Postal Service announced its recommended mailing and shipping dates for holiday mail and packages. The following are recommended send-by dates for expected delivery before Dec. 25.
USPS Announces Holiday Mailing, Shipping Dates
1940 - William S. Hart deeds land for theater at Spruce & 11th Street to American Legion [story]
American Theater
Due to projected power shutoffs related to the current wind advisory, the Child & Family Center’s Centre Pointe Pkwy location, will be closed for in-person services beginning 5 pm Wednesday
Child & Family Center’s Centre Pointe Pkwy Location Closes Due to Power Shutoffs
Beginning Wednesday, November 13, crews will begin the construction of median modifications, paving, grinding and overlay operations along portions of McBean Parkway at Newhall Ranch Road.
Upcoming Lane Closures on McBean Parkway and Newhall Ranch Road
The California Highway Patrol is proud to announce it received a $350,000 grant to address the growing issue of distracted driving on California roads.  
CHP Receives Grant to Combat Adult Distracted Driving in California
The Los Angeles County Economic Development Corporation has once again recognized the city of Santa Clarita as a finalist for the prestigious 2024 "Most Business-Friendly City" award in the category of large cities (population over 60,000).
City of Santa Clarita Named 2024 Most Business-Friendly City Finalist
The County of Los Angeles is experiencing critical fire weather and is under a Particularly Dangerous Situation Red Flag advisory from now until Friday evening. .
Animal Care and Control Urges Emergency Pet Preparedness
SCVNews.com